Should I buy Cognizant (CTSH) stock or is it too late?
⭐ The most reliable of them, either direction: Wedbush — 81% of its targets hit on this sector (382 calls tested). It aims for $70 (+14 %), call made on October 10, 2026, maturing on October 10, 2027 (4 d ago).
Firm-by-firm track record on Cognizant
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wedbush | 100 % | +11.7 % | 7 | $70 +14% |
| Citigroup | 69 % | +6.5 % | 16 | $60 -2% |
| Morgan Stanley | 67 % | +2.5 % | 6 | $51 -17% |
| RBC Capital | 40 % | -2.9 % | 5 | $47 -23% |
| Susquehanna | 60 % | -2.9 % | 5 | $82 +34% |
| JP Morgan | 33 % | -12.4 % | 12 | $55 -10% |
| Jefferies | 100 % | +18.2 % | 5 | — |
| Credit Suisse | 62 % | +8.7 % | 8 | — |
✅ Reasons to believe
- The most reliable firm on CTSH, Wells Fargo (100% hit rate, 4 scored calls), targets $67 (call made on July 30, 2026, maturing on July 30, 2027) (+9%) in its most recent call, and $87 (call made on October 30, 2025, maturing on October 30, 2026) (+42%) in the one coming due soonest.
- 5 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.
- Pays a dividend (3.1% yield), raised for 6 years — regular income on top of potential upside.
- Reasonable valuation (P/E ~13) relative to its sector.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 13 ratings, 7 are neutral.
- Limited upside: the median target is only +7% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
The analyst consensus on CTSH
Median target $66 (+7%) · 13 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Cognizant now?
We won't decide for you. The facts: 46% of analysts rate it a buy, median target $66 (+7%), and Wells Fargo (most reliable on CTSH, 100%) targets $67. Weigh that against valuation (P/E ~13) and volatility. This is not personalized advice.
Is it too late to invest in Cognizant?
Not according to analysts: the median target ($66) is still +7% above the current price ($61) (most reliable on CTSH: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Cognizant still worth investing in?
It depends on the gap between the price ($61) and its estimated value: analysts target $66 on median (+7%), with 46% buys (most reliable on CTSH: Wells Fargo, 100%). Cross-check with their real reliability on CTSH and the cautions above. Information, not advice.
What's the main risk in buying CTSH?
The consensus is not unanimous: of 13 ratings, 7 are neutral.
→ Go deeper: the full Cognizant profile (consensus, analyst reliability, price target, performance).